Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 20,426 shares at $35.33 ($722K) on 2024-06-24, disclosed to the SEC on 2024-07-03.
Scheduled sale ($722k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.33 | 10,213 | $361K | 50.0% |
| 2 | $35.33 | 10,213 | $361K | 50.0% |
| Total | $35.33 avg | 20,426 | $722K | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-06-24 | $2.4M | — | Filing → |
| DYN | SELL | 2024-06-13 | $2.7M | — | Filing → |